Front Cell Neurosci. 2018 Jan 11;11:432.doi: 10.3389/fncel.2017.00432. eCollection 2017.
Neuroprotection Exerted by Netrin-1 and Kinesin Motor KIF1A in Secondary Brain Injury following Experimental Intracerebral Hemorrhage in Rats.
Evid Based Complement Alternat Med. 2018 Jan 9;2018:6139372.doi: 10.1155/2018/6139372. eCollection 2018.
The Protective Effect of Total Flavones from Rhododendron simsii Planch. on Myocardial Ischemia/Reperfusion Injury and Its Underlying Mechanism.
Cell Death Dis. 2018 Jan 9;9(1):11.doi: 10.1038/s41419-017-0014-7.
miRNA-3473b contributes to neuroinflammation following cerebral ischemia.
Exp Cell Res. 2017 Dec 15;361(2):342-352.doi: 10.1016/j.yexcr.2017.11.002. Epub 2017 Nov 2.
Erythropoietin ameliorates early brain injury after subarachnoid haemorrhage by modulating microglia polarization via the EPOR/JAK2-STAT3 pathway.
Cell Death Dis. 2017 Dec 13;8(12):3211.doi: 10.1038/s41419-017-0047-y.
Long non-coding RNA MEG3 functions as a competing endogenous RNA to regulate ischemic neuronal death by targeting miR-21/PDCD4 signaling pathway
Cell Mol Neurobiol. 2017 Nov;37(8):1457-1464.doi: 10.1007/s10571-017-0476-2. Epub 2017 Feb 25.
Regulation of Sirtuin 3-Mediated Deacetylation of Cyclophilin D Attenuated Cognitive Dysfunction Induced by Sepsis-Associated Encephalopathy in Mice.
Chem Sci. 2017 Oct 19;9(1):44-51.doi: 10.1039/c7sc03842a. eCollection 2018 Jan 7.
Caged circular siRNAs for photomodulation of gene expression in cells and mice
Neurol Res. 2017 Sep;39(9):795-802.doi: 10.1080/01616412.2017.1321710. Epub 2017 May 1.
The 15-LO-1/15-HETE system promotes angiogenesis by upregulating VEGF in ischemic brains.
J Neurochem. 2017 Aug;142(3):478-492.doi: 10.1111/jnc.14075. Epub 2017 Jun 20.
Tumor necrosis factor receptor-associated factor 6 participates in early brain injury after subarachnoid hemorrhage in rats through inhibiting autophagy and promoting oxidative stress
Biochem Biophys Res Commun. 2017 Aug 5;489(4):386-392.doi: 10.1016/j.bbrc.2017.05.136. Epub 2017 May 25.
Targeting long non-coding RNA ASBEL with oligonucleotide antagonist for breast cancer therapy
